Total Payments
$50,968
2024 Payments
$7,415
Companies
91
Transactions
862
Medicare Patients
25,888
Medicare Billing
$7.6M
Payment Breakdown by Category
Consulting$27,335 (53.6%)
Food & Beverage$17,954 (35.2%)
Other$3,930 (7.7%)
Travel$1,300 (2.6%)
Education$449.81 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $27,335 | 18 | 53.6% |
| Food and Beverage | $17,954 | 822 | 35.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,930 | 3 | 7.7% |
| Travel and Lodging | $1,300 | 5 | 2.6% |
| Education | $449.81 | 14 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $9,540 | 52 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $6,880 | 9 | $0 (2022) |
| Global Blood Therapeutics, Inc. | $5,135 | 5 | $0 (2022) |
| Exelixis Inc. | $3,826 | 15 | $0 (2024) |
| Karyopharm Therapeutics Inc. | $2,867 | 8 | $0 (2024) |
| Celgene Corporation | $2,825 | 16 | $0 (2024) |
| Janssen Biotech, Inc. | $2,112 | 42 | $0 (2024) |
| Incyte Corporation | $1,344 | 28 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,287 | 61 | $0 (2024) |
| PFIZER INC. | $1,139 | 67 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,415 | 143 | Karyopharm Therapeutics Inc. ($2,828) |
| 2023 | $5,459 | 186 | Gilead Sciences, Inc. ($758.38) |
| 2022 | $12,854 | 116 | Regeneron Pharmaceuticals, Inc. ($6,880) |
| 2021 | $7,115 | 64 | Global Blood Therapeutics, Inc. ($2,554) |
| 2020 | $2,030 | 73 | Puma Biotechnology, Inc. ($584.52) |
| 2019 | $7,356 | 101 | Exelixis Inc. ($2,589) |
| 2018 | $4,477 | 104 | AstraZeneca Pharmaceuticals LP ($2,464) |
| 2017 | $4,262 | 75 | AstraZeneca Pharmaceuticals LP ($3,221) |
All Payment Transactions
862 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $31.10 | General |
| 12/18/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $30.63 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | Genentech USA, Inc. | Itovebi (Biological) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: BioOncology | ||||||
| 12/05/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Education | In-kind items and services | $18.09 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $24.23 | General |
| Category: Hematology | ||||||
| 11/25/2024 | Spectrum Pharmaceuticals Inc. | ROLVEDON (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $30.01 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $29.54 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | Genentech USA, Inc. | Gazyva (Biological), Venclexta | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: BioOncology | ||||||
| 11/14/2024 | Astellas Pharma US Inc | Vyloy (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $98.29 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $31.76 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 11/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ADVATE (Biological) | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: HEMATOLOGY | ||||||
| 11/07/2024 | BeiGene USA, Inc. | TEVIMBRA (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $34.80 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $21.13 | General |
| Category: Hematology/Oncology | ||||||
| 11/05/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Consulting Fee | Cash or cash equivalent | $815.00 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Education | In-kind items and services | $74.99 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $28.54 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.35 | General |
| Category: ONCOLOGY | ||||||
| 10/26/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: Oncology | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Oncology | ||||||
| 10/23/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 73 | 6,383 | 225,681 | $8.4M | $1.6M |
| 2022 | 71 | 6,737 | 283,909 | $10.1M | $2.0M |
| 2021 | 74 | 6,459 | 281,487 | $9.9M | $2.1M |
| 2020 | 70 | 6,309 | 259,104 | $9.9M | $1.9M |
Total Patients
25,888
Total Services
1,050,181
Medicare Billing
$7.6M
Procedure Codes
288
All Medicare Procedures & Services
288 procedure records from CMS Medicare Utilization — Page 1 of 12
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 20 | 8,600 | $1.1M | $369,849 | 34.1% |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 2023 | 13 | 5,140 | $986,880 | $174,065 | 17.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 60 | 9,000 | $459,000 | $164,387 | 35.8% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2023 | 83 | 54,480 | $1.1M | $127,938 | 11.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 477 | 1,119 | $314,062 | $124,732 | 39.7% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 55 | 76,500 | $306,000 | $67,202 | 22.0% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 118 | 515 | $353,290 | $64,321 | 18.2% |
| Q5122 | Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg | Office | 2023 | 23 | 564 | $495,756 | $55,477 | 11.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 407 | 699 | $136,711 | $54,948 | 40.2% |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | Office | 2023 | 18 | 612 | $883,728 | $54,463 | 6.2% |
| J1437 | Injection, ferric derisomaltose, 10 mg | Office | 2023 | 14 | 1,700 | $128,100 | $28,157 | 22.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 152 | 359 | $109,136 | $21,081 | 19.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 544 | 2,516 | $88,060 | $19,100 | 21.7% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 108 | 692 | $105,184 | $18,721 | 17.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 429 | 1,768 | $33,592 | $14,843 | 44.2% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2023 | 212 | 1,527 | $82,458 | $13,916 | 16.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 415 | 1,315 | $81,530 | $13,603 | 16.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 65 | 86 | $33,624 | $13,528 | 40.2% |
| 88185 | Flow cytometry technique for dna or cell analysis, each additional marker | Office | 2023 | 17 | 542 | $94,850 | $12,703 | 13.4% |
| J0185 | Injection, aprepitant, 1 mg | Office | 2023 | 28 | 8,970 | $80,730 | $12,265 | 15.2% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 20 | 166 | $34,030 | $11,412 | 33.5% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 337 | 822 | $47,676 | $10,973 | 23.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 57 | 57 | $28,649 | $10,536 | 36.8% |
| 83520 | Measurement of substance using immunoassay technique | Office | 2023 | 184 | 459 | $83,079 | $7,766 | 9.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 231 | 622 | $57,846 | $7,563 | 13.1% |
About Dr. Jun Sun, M.D
Dr. Jun Sun, M.D is a Hematology & Oncology healthcare provider based in Clinton, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/09/2008. The National Provider Identifier (NPI) number assigned to this provider is 1306097209.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jun Sun, M.D has received a total of $50,968 in payments from pharmaceutical and medical device companies, with $7,415 received in 2024. These payments were reported across 862 transactions from 91 companies. The most common payment nature is "Consulting Fee" ($27,335).
As a Medicare-enrolled provider, Sun has provided services to 25,888 Medicare beneficiaries, totaling 1,050,181 services with total Medicare billing of $7.6M. Data is available for 4 years (2020–2023), covering 288 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Clinton, MD
- Active Since 10/09/2008
- Last Updated 08/18/2011
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1306097209
Products in Payments
- LIBTAYO (Biological) $7,071
- OXBRYTA (Drug) $5,214
- Cabometyx (Drug) $3,605
- TAGRISSO (Drug) $3,280
- XPOVIO (Drug) $2,867
- Luspatercept (Drug) $2,520
- FASLODEX (Drug) $2,379
- LYNPARZA (Drug) $2,108
- DARZALEX (Biological) $1,586
- IMFINZI (Biological) $1,490
- Trodelvy (Drug) $798.30
- KEYTRUDA (Biological) $774.21
- NERLYNX (Drug) $584.52
- ELIQUIS (Drug) $411.79
- OPDIVO (Biological) $362.51
- Enhertu (Drug) $354.86
- FOTIVDA (Drug) $346.19
- Lenvima (Drug) $330.85
- XTANDI (Drug) $313.29
- JAKAFI (Drug) $308.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Clinton
Jose Mendoza, M.d, M.D
Hematology & Oncology — Payments: $39,626
Hematology & Oncology $39,626
Deepnarayan Tiwarri, M.d, M.D
Hematology & Oncology — Payments: $19,386
Hematology & Oncology $19,386
Ankit Madan, M.b.b.s, M.B.B.S
Hematology & Oncology — Payments: $12,862
Hematology & Oncology $12,862
Nicholas Demonaco, M.d, M.D
Hematology & Oncology — Payments: $11,643
Hematology & Oncology $11,643
Rita Gupta, M.d, M.D
Hematology & Oncology — Payments: $10,935
Hematology & Oncology $10,935
Dr. Jorge Perez-Cardona, M.d, M.D
Hematology & Oncology — Payments: $6,089
Hematology & Oncology $6,089